EDIT
Editas Medicine Inc
2.80$
+0.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,025.4% | -98.1% | -54.8% | -88.1% | +50,070.5% | -84.8% | -23.2% | +110.8% | +228.0% | -88.6% | +320.0% | – | |
| – | -3.2% | -3.9% | +0.8% | +12.6% | +2,940.1% | -45.3% | -39.2% | +22.2% | -95.9% | -40.0% | – | – | |
| – | +1,432.8% | -100.5% | – | – | – | – | – | – | – | -90.5% | +406.4% | – | |
| – | +1,176.0% | -30.4% | +11.4% | -9.8% | +2.0% | -45.3% | -39.2% | +22.2% | +38.6% | -89.7% | +612.8% | – | |
| – | -3.5% | +33.8% | -5.9% | -0.6% | -9.6% | -18.2% | -3.9% | -4.2% | -7.8% | -9.9% | +13.4% | – | |
| – | +52.9% | -19.2% | +6.4% | -9.7% | -55.4% | +89.7% | -28.2% | -68.4% | +214.7% | -29.4% | +11.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | -8.8% | +18.8% | +176.6% | -83.8% | -1.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.